You are here

Mass. biotech reaps Monsanto deal

Citations

Title

Mass. biotech reaps Monsanto deal

From Ira Kantor's article in The Boston Herald:

Gregory Conko, senior fellow at the Competitive Enterprise Institute in Washington, D.C., and co-author of “The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution,” said RNAi technology tools “are not dangerous.”

“It’s only what you do with the technology that may or may not produce a product that is dangerous,” he said.